Advertisement

Gastroenterology

Home Gastroenterology

September 2015 Briefing – Gastroenterology

Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for September 2015. This roundup includes the latest...
Liver transplant recipients have a lower rate of infection with receipt of prebiotics and probiotics before surgery

Probiotics Reduce Rate of Infection After Liver Transplant

Meta-analysis shows reduction in rate of infection, shorter length of hospital, ICU stay
The presence of four types of gut bacteria in infancy may reduce a child's risk for asthma

Dysbiosis in Infancy Tied to Asthma Risk in Children

Four bacterial taxa implicated in risk of asthma
Several strategies can be implemented in order to better use electronic health records for patient care and efficiency

Strategies Provided for Improving EHR Efficiency

Tips include educating staff about preferences and processes, using own templates to reduce editing
Numerous studies have extolled the health benefits of the Mediterranean diet. Now

More Support for High-Fiber, Mediterranean Diet

Beneficial effects for plant-based diet but not limited to vegetarian or vegan diets
Early use of precut sphincterotomy does not increase the risk of pancreatitis but does increase rates of primary cannulation during endoscopic retrograde cholangiopancreatography

Early Precut Sphincterotomy Ups Primary Cannulation Rates

No increase in post-endoscopic retrograde cholangiopancreatography pancreatitis
Daily aspirin might extend survival for patients with cancers of the gastrointestinal tract

More Evidence Daily Aspirin May Protect Against GI Cancer

Four-year study found survival doubled for GI cancer patients who took low-dose pill each day
An experimental study suggests that ebselen might be a new weapon in the fight against Clostridium difficile. The research

Ebselen Shows Potential for Drug-Resistant Clostridium difficile

Mouse study finds treatment safe and effective; currently unknown if therapy will help in humans
A new report commissioned by the U.S. government contends that most Americans will encounter at least one diagnostic error in their lifetime

IOM: Most U.S. Patients Will Experience Diagnostic Error

Panel urges changes to an increasingly complex health care system
The combination pill Lonsurf (trifluridine and tipiracil) has been approved by the U.S. Food and Drug Administration to treat metastatic colorectal cancer in patients who aren't responding to other treatments

FDA Approves Lonsurf for Metastatic Colorectal Cancer

For patients with metastatic CRC previously treated with chemotherapy, biological therapy